Haemonetics Total Assets 2010-2025 | HAE

Haemonetics total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
Haemonetics Annual Total Assets
(Millions of US $)
2025 $2,451
2024 $2,196
2023 $1,935
2022 $1,860
2021 $1,820
2020 $1,267
2019 $1,275
2018 $1,237
2017 $1,239
2016 $1,319
2015 $1,485
2014 $1,514
2013 $1,462
2012 $911
2011 $833
2010 $761
2009 $650
Haemonetics Quarterly Total Assets
(Millions of US $)
2025-03-31 $2,451
2024-12-31 $2,531
2024-09-30 $2,525
2024-06-30 $2,541
2024-03-31 $2,196
2023-12-31 $2,200
2023-09-30 $2,011
2023-06-30 $1,962
2023-03-31 $1,935
2022-12-31 $1,878
2022-09-30 $1,865
2022-06-30 $1,821
2022-03-31 $1,860
2021-12-31 $1,831
2021-09-30 $1,801
2021-06-30 $1,794
2021-03-31 $1,820
2020-12-31 $1,318
2020-09-30 $1,418
2020-06-30 $1,433
2020-03-31 $1,267
2019-12-31 $1,238
2019-09-30 $1,191
2019-06-30 $1,260
2019-03-31 $1,275
2018-12-31 $1,228
2018-09-30 $1,266
2018-06-30 $1,241
2018-03-31 $1,237
2017-12-31 $1,312
2017-09-30 $1,271
2017-06-30 $1,251
2017-03-31 $1,239
2016-12-31 $1,306
2016-09-30 $1,335
2016-06-30 $1,317
2016-03-31 $1,319
2015-12-31 $1,336
2015-09-30 $1,419
2015-06-30 $1,427
2015-03-31 $1,485
2014-12-31 $1,474
2014-09-30 $1,475
2014-06-30 $1,477
2014-03-31 $1,514
2013-12-31 $1,488
2013-09-30 $1,484
2013-06-30 $1,480
2013-03-31 $1,462
2012-12-31 $1,474
2012-09-30 $1,455
2012-06-30 $928
2012-03-31 $911
2011-12-31 $848
2011-09-30 $824
2011-06-30 $853
2011-03-31 $833
2010-12-31 $783
2010-09-30 $738
2010-06-30 $698
2010-03-31 $761
2009-12-31 $702
2009-09-30 $714
2009-06-30 $692
2009-03-31 $650
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $3.667B $1.361B
Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $237.070B 28.51
Boston Scientific (BSX) United States $155.016B 38.81
Stryker (SYK) United States $151.431B 31.66
EssilorLuxottica (ESLOY) France $128.578B 0.00
Medtronic (MDT) Ireland $113.826B 16.14
Lonza Group Ag (LZAGY) Switzerland $51.396B 0.00
Haleon (HLN) United Kingdom $46.515B 26.54
ResMed (RMD) United States $37.575B 28.22
GE HealthCare Technologies (GEHC) United States $34.776B 16.51
Agilent Technologies (A) United States $34.216B 22.31
Terumo (TRUMY) Japan $26.620B 34.58
Koninklijke Philips (PHG) Netherlands $23.303B 16.35
Insulet (PODD) United States $21.112B 82.87
Zimmer Biomet Holdings (ZBH) United States $18.610B 11.95
Baxter (BAX) United States $16.026B 11.97
Smith & Nephew SNATS (SNN) United Kingdom $13.402B 0.00
Demant (WILYY) Denmark $9.110B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.748B 23.48
Lantheus Holdings (LNTH) United States $5.495B 13.86
Prestige Consumer Healthcare (PBH) United States $3.969B 17.73
Perrigo (PRGO) Ireland $3.771B 9.56
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.393B 28.20
ICU Medical (ICUI) United States $3.321B 24.49
QuidelOrtho (QDEL) United States $2.015B 13.86
LeMaitre Vascular (LMAT) United States $1.891B 42.27
AtriCure (ATRC) United States $1.594B 0.00
Acuren (TIC) United States $1.327B 0.00
AdaptHealth (AHCO) United States $1.269B 12.88
Green Thumb Industries (GTBIF) United States $1.158B 26.05
Neogen (NEOG) United States $1.103B 14.11
Phibro Animal Health (PAHC) United States $1.079B 13.79
BioLife Solutions (BLFS) United States $1.029B 0.00
InMode (INMD) Israel $0.937B 9.45
Kestra Medical Technologies (KMTS) United States $0.813B 0.00
Owens & Minor (OMI) United States $0.728B 6.04
CeriBell (CBLL) United States $0.671B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.639B 0.00
Evolus (EOLS) United States $0.593B 0.00
Curaleaf Holdings (CURLF) Canada $0.544B 0.00
Valneva SE (VALN) France $0.487B 0.00
Capricor Therapeutics (CAPR) United States $0.443B 0.00
Tilray Brands (TLRY) Canada $0.424B 0.00
Surmodics (SRDX) United States $0.419B 0.00
VAREX IMAGING (VREX) United States $0.353B 12.98
Quanterix (QTRX) United States $0.334B 0.00
SNDL (SNDL) Canada $0.321B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.301B 0.00
Cerus (CERS) United States $0.283B 0.00
Viemed Healthcare (VMD) United States $0.277B 23.33
Sanuwave Health (SNWV) United States $0.276B 0.00
ZimVie (ZIMV) United States $0.274B 12.46
Cresco Labs (CRLBF) United States $0.258B 0.00
Sanara MedTech (SMTI) United States $0.256B 0.00
Brainsway (BWAY) Israel $0.245B 64.88
Aurora Cannabis (ACB) Canada $0.242B 71.67
Biote (BTMD) United States $0.225B 6.34
OraSure Technologies (OSUR) United States $0.225B 0.00
Canopy Growth (CGC) Canada $0.208B 0.00
TriSalus Life Sciences (TLSI) United States $0.195B 0.00
Verano Holdings (VRNOF) United States $0.190B 0.00
High Tide (HITI) Canada $0.187B 0.00
Utah Medical Products (UTMD) United States $0.186B 15.18
Organigram Global (OGI) Canada $0.177B 0.00
Omeros (OMER) United States $0.174B 0.00
Exagen (XGN) United States $0.149B 0.00
Vireo Growth (VREOF) United States $0.141B 0.00
FitLife Brands (FTLF) United States $0.133B 16.35
Jin Medical (ZJYL) China $0.099B 0.00
Fonar (FONR) United States $0.097B 12.50
TerrAscend (TSNDF) Canada $0.091B 0.00
Veru (VERU) United States $0.086B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
Apyx Medical (APYX) United States $0.085B 0.00
Cytosorbents (CTSO) United States $0.081B 0.00
Zynex (ZYXI) United States $0.080B 0.00
MacroGenics (MGNX) United States $0.079B 0.00
Quipt Home Medical (QIPT) United States $0.076B 0.00
InterCure (INCR) Israel $0.067B 0.00
Agape ATP (ATPC) $0.067B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Nephros (NEPH) United States $0.043B 57.57
Modular Medical (MODD) United States $0.038B 0.00
United-Guardian (UG) United States $0.037B 12.75
Safety Shot (SHOT) United States $0.033B 0.00
Rockwell Medical (RMTI) United States $0.028B 0.00
Allurion Technologies (ALUR) United States $0.018B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.013B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
IM Cannabis (IMCC) Canada $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00